Treatment of patients with brain metastases from ovarian cancer: clinical observation
The capacity of drugs to penetrate across the blood-brain barrier (BBB) is primarily traditionally taken into account on choosing chemotherapy (CT) regimens for patients with brain metastatic involvement. P aclitaxel and carboplatin have a low ability to cross the BBB in its normal state. As of now,...
Saved in:
Main Authors: | V. B. Karakhan (Author), D. R. Naskhletashvili (Author), N. V. Sevyan (Author) |
---|---|
Format: | Book |
Published: |
ABV-press,
2014-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cerebral metastases of endometrial carcinoma. Diagnostic and neurosurgical aspects
by: N. V. Sevyan, et al.
Published: (2014) -
New treatment options for patients with brain metastases from ovarian cancer
by: A. G. Kedrova, et al.
Published: (2021) -
OVARIAN CANCER WITH SOLITARY BRAIN METASTASIS. A CLINICAL CASE OF PROLONGED (OVER 7 YEARS) COMPLETE REMISSION AFTER COMBINED TREATMENT
by: N. V. Sevyan, et al.
Published: (2018) -
Metastatic brain lesions in patients with cervical cancer: a case report
by: Nadezhda V Sevyan, et al.
Published: (2019) -
Multiple metastases from ovarian cancer
by: Daleep Singh, et al.
Published: (2014)